Czechia· CZ-0194695
KINERET
A anakinra product containing anakinra, registered in Czechia by Swedish Orphan Biovitrum AB (publ), Stockholm. The same ATC class is registered in 13 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Anakinra is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AC03 (anakinra), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Anakinra · ATC L04AC03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ANAKINRA
- Manufacturer
- Swedish Orphan Biovitrum AB (publ), Stockholm
- Country
- Czechia (CZ)
- ATC code
- L04AC03
- ATC class
- Anakinra
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl01946957X0,67MLCZK 6065.28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
375 interactions on record for anakinra.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Anakinra · interactions on record
375 records
- 31 severe
- 337 moderate
- 7 minor
Most severe, free to view
- CladribineL01BB04severe
- PrednisoloneA07EA01moderate
- HydrocortisoneA07EA02moderate
- PrednisoneA07EA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Anakinra in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumKineret 100 mg/0.67 mlSwedish Orphan Biovitrum (Publ)
- SpainKINERET 100 mg/0,67 ml solucion inyectable en jeringa precargadaSwedish Orphan Biovitrum Ab (Publ)
- IcelandKineret*Swedish Orphan Biovitrum AB (publ)
- PolandKineretSwedish Orphan Biovitrum AB
- SwedenKineret 100 mg/0,67 ml Injektionsvätska, lösning i förfylld sprutaSwedish Orphan Biovitrum AB (publ)
- FinlandKineretSwedish Orphan Biovitrum AB (publ)
- FranceKINERET 100 mg/0,67 mL, solution injectable en seringue préremplieSWEDISH ORPHAN BIOVITRUM INTERNATIONAL (SUEDE)
- United KingdomKineret 100mg/0.67ml solution for injection pre-filled syringesSwedish Orphan Biovitrum Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kineret
- Liechtenstein · Kineret
- Norway · Kineret
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0343f00f-dd27-4fe9-8ca2-45c8dcaf6a7b GET /v1/drugs/0343f00f-dd27-4fe9-8ca2-45c8dcaf6a7b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL ISP",
"source": "sukl",
"strength": "100MG/0,67ML",
"pack_size": "7X0,67ML",
"substance": "ANAKINRA",
"cz_kod_sukl": "0194695",
"product_type": "BT",
"substance_codes": "14073",
"registration_state": "R",
"registration_number": "EU/1/02/203/006"
}See everything about anakinra.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.